Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41^st Annual Strategic Decisions Conference on Wednesday, May 28, 2025.

The company will take part in a fireside chat beginning at 3:30 p.m. ET.

Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521973995/en/

Media Relations:

media@bms.com



Investor Relations:

investor.relations@bms.com

Source: Bristol Myers Squibb